| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
KK-LC-1 Blocking Peptide is synthetically produced from the 20-70 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
CT83 |
| Gene ID: |
203413 |
| Uniprot ID: |
KKLC1_HUMAN |
| Immunogen Region: |
20-70 |
| Immunogen: |
Synthetic peptide taken within amino acid region 20-70 on human Kita-kyushu lung cancer antigen 1. |
| Peptide Name | Kita-Kyushu Lung Cancer Antigen 1Kk-Lc-1Cancer/Testis Antigen 83 |
| Cellular Localisation | Cell MembraneSingle-Pass Type Ii Membrane Protein |
| Alternative Peptide Names | Kita-Kyushu Lung Cancer Antigen 1 proteinKk-Lc-1 proteinCancer/Testis Antigen 83 proteinCT83 proteinCXorf61 proteinKKLC1 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
